Bedaquiline Enantiomer Impurity Fumarate Salt

Bedaquiline Enantiomer Impurity Fumarate Salt is a premium pharmaceutical reference standard designed for precise enantiomeric impurity identification, chiral separation studies, and Bedaquiline-related impurity profiling. With molecular formula C₃₆H₃₅BrN₂O₆ and molecular weight 671.58 g/mol, this Bedaquiline fumarate salt impurity standard supports chiral HPLC analysis, LC-MS confirmation, related-substances testing, analytical method development and validation, stability studies, and pharmaceutical quality control. It is an ideal choice for pharmaceutical laboratories, CROs, formulation developers, and regulated QC facilities involved in Bedaquiline stereoisomer analysis and anti-tuberculosis drug impurity characterization.

Manasa Life Sciences offers complete analytical and documentation support, including HPLC purity, chiral HPLC, LC-MS/MS, ¹H and ¹³C NMR, FTIR, TGA, potency/assay COA, chromatograms, spectral data, and batch traceability records. Testing and documentation can be customized to comply with applicable ICH, EMA, EP, and USP regulatory guidelines, along with GLP and GDP practices, within the agreed project scope. Contact the team for detailed product specifications, characterization reports, potency COA, pricing, availability, and tailored Bedaquiline enantiomer impurity reference standards.